Heart attacks can strike suddenly—do you know how to respond?

pharmanewsdaily- January 12, 2025 0

A heart attack, medically referred to as a myocardial infarction, is a life-threatening condition that demands urgent attention. Statistics reveal that nearly half of heart ... Read More

TiGenix reports success for AlloCSC-01 in Phase I/II heart failure study

pharmanewsdaily- March 13, 2017 0

TiGenix, a Belgium-based biopharmaceutical company, has announced promising results from its Phase I/II study assessing the safety and efficacy of AlloCSC-01, its innovative stem cell ... Read More